➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Mallinckrodt
Merck
AstraZeneca
Johnson and Johnson

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

Abraxis Pharm Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?

ABRAXIS PHARM has one hundred and thirteen approved drugs.



Summary for Abraxis Pharm
US Patents:0
Tradenames:63
Ingredients:60
NDAs:113

Drugs and US Patents for Abraxis Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm SODIUM HEPARIN heparin sodium INJECTABLE;INJECTION 017033-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Abraxis Pharm CEPHALOTHIN SODIUM cephalothin sodium INJECTABLE;INJECTION 062666-002 Jun 10, 1987 DISCN No No   Start Trial   Start Trial
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 089143-001 Mar 28, 1986 DISCN No No   Start Trial   Start Trial
Abraxis Pharm DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070364-001 Dec 4, 1985 DISCN No No   Start Trial   Start Trial
Abraxis Pharm BRETYLIUM TOSYLATE bretylium tosylate INJECTABLE;INJECTION 071298-001 Feb 13, 1987 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Harvard Business School
Medtronic
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.